Clinical Takeaway In this pilot study, short-term low-dose CBD supplementation did not improve glucose tolerance, gut microbiome composition, or inflammatory markers in sedentary adults with overweight or obesity. While animal studies and...
Cannabidiol mitigates high-fat-diet-induced early-stage inflammation in two adipose tissue fat depots of Wistar rats.
Cannabidiol (CBD) has potential for treating obesity-induced inflammation; thus, we studied the influence of CBD on the accumulation of lipid precursors of i…
Cannabinoid Clinical Trials: CBD, Glucose & Gut Health
Clinical Takeaway In this pilot study, short-term low-dose CBD supplementation did not improve glucose tolerance, alter gut microbiome composition, or reduce inflammation in sedentary adults with overweight or obesity. While animal studies...
Cannabidiol & Glucose Tolerance: Clinical Trial Evidence
Clinical Takeaway In this pilot study, short-term low-dose CBD supplementation did not improve glucose tolerance or meaningfully alter the gut microbiome in sedentary adults with overweight or obesity. While animal studies and...
Cannabinoid Clinical Trials: CBD, Glucose & Gut Health
Clinical Takeaway In this pilot study, short-term low-dose CBD supplementation did not improve glucose tolerance or beneficially alter the gut microbiome in sedentary adults with overweight or obesity. While animal studies and...
Cannabinoid Clinical Trials: CBD, Glucose & Gut Health
Clinical Takeaway In this pilot study, short-term low-dose CBD supplementation did not improve glucose tolerance, alter gut microbiome composition, or reduce inflammation in sedentary adults with overweight or obesity. While animal research...
Cannabinoid Clinical Trials: CBD, Glucose & Gut Health
Clinical Takeaway In this pilot study, short-term low-dose CBD supplementation did not meaningfully change blood sugar regulation or gut bacterial composition in overweight or obese sedentary adults. While animal research has suggested...
Cannabinoid Clinical Trials: CBD, Glucose & Gut Health
Clinical Takeaway In this pilot study, short-term low-dose CBD supplementation did not improve glucose tolerance or meaningfully alter the gut microbiome in sedentary adults with overweight or obesity. While animal studies have...
Cannabidiol & Glucose Tolerance: Clinical Evidence Review
Clinical Takeaway In this pilot study, short-term low-dose oral CBD did not significantly improve glucose tolerance or produce measurable changes in the gut microbiome in sedentary adults with overweight or obesity. While...
Cannabinoid Clinical Trials: CBD, Glucose & Gut Health
Clinical Takeaway In this pilot study, short-term low-dose CBD supplementation did not produce measurable improvements in glucose tolerance, gut microbiome composition, or inflammatory markers in sedentary adults with overweight or obesity. While...